DiagNodus Ltd. products

DiagNodus has designed and patented methods for non-invasive collection and analysis of samples indicative of the state of the human bowel. The technology is based upon disease biomarker detection. The approach addresses a range of diagnostic, screening and monitoring applications within the field of colorectal disease, in particular targeting inflammatory bowel disease (IBD) and colorectal cancer (CRC). The company has already established analytical laboratory techniques employing quantitative immunochemical determination of IBD markers and is now developing point of care test kits, which will be made as disposable single-application units designed for rapid testing.